Developer docs
API playgroundTry for free, no card

Search company profiles

Arkana Laboratories

Full company profile

uuid0003a7z

Namestring
Arkana Laboratories
Legal namestring
Arkana Laboratories
Websiteurl
arkanalabs.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Arkana Laboratories is a center for esoteric pathology headquartered in Little Rock, Arkansas, founded in 2001 by Dr. Patrick Walker as Nephropathology Associates and rebranded under its current name in 2016. The firm operates as the largest renal pathology laboratory in the United States, with 25 board-certified renal pathologists and 3 neuropathologists supported by more than 140 technical and administrative staff, processing more than 90 kidney biopsies per day from referring physicians and hospitals across 46 states. Core diagnostic capabilities span light microscopy, immunofluorescence, electron microscopy, molecular diagnostics (PCR, digital PCR, NanoString), mass spectrometry, and multiplex immunofluorescence imaging; the firm runs a refined 9-hour same-day turnaround workflow for renal biopsies and a 3–5 day turnaround for neuromuscular (muscle and nerve) biopsies.

The business generates revenue through fee-for-service esoteric pathology testing billed to hospitals or third-party payers, supplemented by a PCR-based APOL1 Genotyping Assay (with a No Cost to Patient program sponsored by Vertex Pharmaceuticals), contract research organization (CRO) services for pharmaceutical and biotechnology sponsors via a GCLP-trained, CAP/CLIA/NY-State-certified central lab, a Clinical Biomarker Center offering multiplex imaging in partnership with Quanterix (Akoya) and Vizgen (Ultivue), and a Biorepository supporting kidney disease research. Distribution is direct-to-provider: FedEx-shipped biopsy kits, specimen return logistics, physician phone consultation, faxed reports, and the Arkana Connect mobile app for real-time result access. The firm also operates a one-year renal pathology fellowship, a six-month mid-career transition program, and an extensive educational content program (blog, quizzes, podcast) that functions as a low-cost physician referral channel.

Arkana remains privately held with no disclosed outside investment or parent company. Its research footprint includes 505+ peer-reviewed publications, a 500+-case kidney biopsy biorepository, and access to approximately 50,000 kidney biopsy records spanning 2001–2024, supporting both academic research and pharma-sponsored clinical trial central pathology work. Strategic priorities visible from 2012 onward include sequential vertical expansion (molecular, neuropathology, clinical trials, biomarker center), talent depth as the most concentrated renal pathologist team globally, and partnership-led growth into pharma-sponsored genetic testing channels.

Short descriptiontext

Arkana Laboratories is a privately held esoteric pathology lab in Little Rock, Arkansas, providing same-day renal biopsy interpretation, neuromuscular diagnostics, APOL1 genotyping, and CRO services to nephrologists, hospitals, and pharma sponsors across 46 U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLittle Rock, United States
HQ citystring
Little Rock
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
renal pathology services, neuropathology diagnostics, biopsy interpretation, APOL1 genotyping, contract research services
Industry1 code
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
NAICS code3 codes
  • Medical Laboratories621511
  • Other Scientific and Technical Consulting Services541690
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Esoteric Pathology Diagnostic Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Laboratory Diagnostic Services
TypeTransaction Fee
Description

Arkana generates revenue by providing fee-for-service esoteric pathology diagnostic testing to hospitals, clinics, nephrologists, and pathologists across 46 states. Services include renal biopsy interpretation (light microscopy, immunofluorescence, electron microscopy), neuropathology (muscle and nerve biopsy analysis), and APOL1 genotyping. Billing can be directed to hospitals or third-party payers.

arkanalabs.com
2APOL1 Genotyping Assay
TypeTransaction Fee
Description

PCR-based genetic testing for APOL1 risk variants (G1, G2, M1) with 24-hour turnaround. Revenue generated from standard laboratory fees for the APOL1 Genotyping Assay. A no-cost testing program is sponsored by Vertex Pharmaceuticals for eligible patients (African ancestry with proteinuria or decreased kidney function, without diabetes).

arkanalabs.com
3Contract Research Organization (CRO) Services
TypeProfessional Services
Description

Fee-for-service contract research for pharmaceutical and biotechnology companies, academic institutions. Services include board-certified pathologist reads, biomarker identification, stains, transmission electron microscopy, digital PCR, NanoString assays, RNA/DNA extraction, whole slide scanning, AI-based quantitative image analysis, multiplex immunofluorescence, confocal microscopy, laser capture microdissection, and prospective/retrospective referral services. Served as central anatomic pathology lab for clinical trials in glomerulonephritis.

arkanalabs.com
4Biorepository Services
TypeData Monetisation
Description

De-identified human biologic sample collection and archiving for research purposes, supporting development of diagnostic tests and biomarkers for kidney disease. Samples used to develop serologic and molecular tests.

arkanalabs.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain
Pricing details2 tiers
1No Cost to Patient APOL1 Testing Program (Vertex Pharmaceuticals sponsored)
ModelOtherBilling cadencePay-as-you-go
Notes

No cost to eligible patients meeting criteria: African ancestry (self-reported Black, African American, African, Afro-Caribbean, Hispanic, or Latino), presence of protein in urine or decreased kidney function (CKD Stages 1-4), absence of diabetes, not currently on dialysis and no history of kidney transplant. Vertex Pharmaceuticals covers cost of genetic counseling for eligible patients.

arkanalabs.com
2Standard pathology testing services - billing to hospital or third-party
ModelOtherBilling cadencePay-as-you-go
Notes

We can handle billing any way you wish. We can bill your hospital directly or third-party bill.

arkanalabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Arkana Laboratories is a specialized esoteric pathology laboratory that provides kidney and neuromuscular biopsy interpretation, genetic testing (APOL1 genotyping), and contract research services for healthcare providers and pharmaceutical sponsors. It operates the largest team of board-certified renal pathologists in the United States, processing 90+ kidney biopsies per day from 46 states with a 9-hour turnaround, and delivers results via phone consultation, fax, web portal, and a mobile app.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Same-day renal biopsy results - from specimen receipt to final results delivered in 9 hours
+6 more records
Product overview1 text field

Arkana Laboratories is a center for esoteric pathology offering a comprehensive portfolio of diagnostic and research services. The core services include renal pathology with same-day biopsy results (light microscopy, immunofluorescence, and electron microscopy), neuropathology for muscle and nerve biopsies, APOL1 genotyping assay (PCR-based, 24-hour turnaround), and contract research services for clinical trials. Supporting services include a biorepository for kidney disease research and a Clinical Biomarker Center for multiplex imaging. The company also provides educational programs including a one-year renal pathology fellowship and a six-month mid-career transition program. Arkana Connect provides mobile access to patient results. All services are delivered from a single location in Little Rock, Arkansas, with the company processing thousands of kidney biopsies annually from 46 states.

Product and service7 records
1Renal Pathology Services
CategoryRenal Pathology Diagnostic Services
Description

Same-day renal biopsy interpretation and diagnosis combining light microscopy, immunofluorescence (IF), and electron microscopy (EM), with clinicopathologic discussion delivered by board-certified nephropathologists. Arkana processes 90+ kidney biopsies per day for adult, pediatric, and transplant cases received from 46 states.

2Neuropathology Services
CategoryNeuropathology Diagnostic Services
Description

Expert analysis of muscle and nerve biopsies by three board-certified neuropathologists for inflammatory myopathies, muscular dystrophies, metabolic and congenital myopathies, and neuromuscular disease diagnosis. Includes neurosurgical consultations and autopsy brain analysis, with rapid 3–5 day turnaround and 24-hour preliminary results; accepts fresh or frozen tissue.

3APOL1 Genotyping Assay
CategoryGenetic / Molecular Diagnostics
Description

PCR-based genetic test detecting APOL1 kidney risk variants (G1, G2, and the M1 protective modifier) in patients of African ancestry, with 24-hour turnaround. A no-cost testing program is available to eligible patients through sponsorship by Vertex Pharmaceuticals and Metis Genetics pre-test counseling.

4Contract Research Services (CRO)
CategoryContract Research / Clinical Trial Central Lab
Description

GCLP-trained, CAP/CLIA/NY State-certified contract research organization (CRO) services for pharmaceutical, biotech, and academic sponsors. Includes board-certified pathologist reads, novel biomarker identification, transmission electron microscopy, digital PCR, NanoString assays, RNA/DNA extraction, whole slide scanning, AI-based quantitative image analysis, multiplex immunofluorescence, confocal microscopy, and laser capture microdissection. Arkana has served as a central anatomic pathology laboratory for clinical trials, including in glomerulonephritis.

5Arkana Biorepository
CategoryResearch Biorepository Services
Description

Collection and archiving of de-identified human biologic samples for kidney disease research, supporting development of serologic and molecular diagnostic tests and biomarkers. The biorepository holds hundreds of well-characterized kidney biopsy cases spanning conditions such as membranous glomerulopathy, lupus nephritis, and fibrillary glomerulopathy. Mobile phlebotomy is available via partner ExamOne.

6Clinical Biomarker Center
CategoryMultiplex Imaging / Biomarker Services
Description

Certified partner with Quanterix (formerly Akoya Biosciences) and Vizgen (formerly Ultivue) offering multiplex imaging of human tissues for biomarker discovery. Capabilities include Leica BondRx automated staining, Quanterix PhenoImagerHT fluorescence and brightfield whole slide scanning with InForm spectral unmixing, Halo AI image processing, Halo Link remote collaboration, Olympus VS200 high-throughput fluorescence and brightfield scanning, and Leica laser scanning confocal microscopy.

7Arkana Connect Mobile App
CategoryPhysician Results Access Platform
Description

Mobile application (iOS and Android) providing physicians secure access to patient biopsy results, including reports and diagnostic images, with two-factor authentication.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Vertex Pharmaceuticals sponsors the No Cost to Patient APOL1 Genotyping Program, enabling healthcare providers to order APOL1-risk variant testing at no cost for qualifying patients (African ancestry with proteinuria or CKD Stages 1-4, without diabetes). Vertex also covers cost of genetic counseling for eligible patients. This partnership advances awareness and diagnosis of APOL1-mediated kidney disease.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Metis Genetics provides pre-test genetic counseling to eligible patients in the No Cost to Patient APOL1 Genotyping Program, reviewing benefits and limitations of genetic testing. Genetic counseling available before testing and after results for patients testing positive for APOL1 high-risk variants. Sponsored by Vertex Pharmaceuticals.

Strategic tierCoreTypeTechnology or Integration
Description

Arkana Laboratories' Clinical Biomarker Center is a certified partner in Quanterix's CRO Partnership Program, specializing in multiplex imaging of human tissues. Uses Quanterix PhenoImagerHT fluorescence and brightfield whole slide scanning microscope with InForm software for spectral unmixing. Also uses Vizgen (formerly Ultivue) technology.

Strategic tierCoreTypeTechnology or Integration
Description

Arkana Laboratories' Clinical Biomarker Center specializes in multiplex imaging of human tissues in partnership with Vizgen. Vizgen technology complements Quanterix PhenoImagerHT and Leica BondRx for advanced tissue imaging services.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

ExamOne provides mobile phlebotomy services for the Arkana Biorepository program. ExamOne sends a mobile phlebotomist to a location of the patient's choosing (home or office) to collect biological samples. Arkana Labs covers cost of mobile phlebotomy and shipping.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ARUP Laboratories is a nonprofit reference laboratory affiliated with the University of Utah, providing esoteric diagnostic testing including renal pathology, neuropathology, and genetic testing. It competes directly with Arkana for hospital system contracts and offers comparable subspecialty pathologist reads.

TypeDirect peer
Description

MNG Laboratories is a specialty neuropathology and molecular genetic testing laboratory (now part of Labcorp) focused on neuromuscular disease diagnostics including muscle and nerve biopsy interpretation. It is the most direct head-to-head competitor to Arkana's neuropathology service line.

TypeBroad incumbent
Description

Quest Diagnostics is one of the largest U.S. clinical laboratory networks, offering anatomic pathology, esoteric testing, and increasingly subspecialty renal and molecular diagnostics. It competes with Arkana primarily through hospital system contracts and a national logistics network.

TypeBroad incumbent
Description

Labcorp is a major clinical laboratory network with a growing esoteric and specialty pathology portfolio, including the acquired MNG Laboratories for neuromuscular diagnostics. It is a broad competitor to Arkana's diagnostic and CRO services across hospitals and physician offices.

TypeDirect peer
Description

PreventionGenetics is a CLIA-certified clinical DNA testing laboratory (now part of Exact Sciences) offering genetic assays including kidney disease risk testing. It is a direct comparable to Arkana's APOL1 genotyping assay and broader molecular diagnostic services.

TypeEmerging player
Description

NeoGenomics is a specialty oncology-focused clinical laboratory with growing activity in molecular and anatomic pathology CRO services for pharma clinical trials. It overlaps with Arkana's CRO/biopharma service line, particularly for central pathology lab partnerships.

TypeEmerging player
Description

PathAI is an AI-powered pathology technology company providing machine-learning image analysis tools for diagnostic and CRO applications. It is comparable to Arkana's emerging AI/machine-learning biopsy adequacy work and contract research image analytics capabilities.

TypeBroad incumbent
Description

Sonic Healthcare USA operates a national network of specialty and reference laboratories including anatomic pathology and esoteric testing services. It competes with Arkana as a broader reference lab alternative for hospital systems seeking subspecialty renal pathology reads.

TypeOthers
Description

Eurofins Scientific is a global laboratory testing group with a substantial clinical diagnostics and pharmaceutical CRO footprint, including specialty biomarker and central lab services. It is comparable as an adjacent CRO/biomarker player serving similar pharmaceutical clients in clinical trials.

TypeBroad incumbent
Description

Mayo Clinic Laboratories is the reference laboratory arm of Mayo Clinic, offering an extensive esoteric test menu including renal pathology consultations and second-opinion biopsy interpretation. It competes with Arkana for hospital referrals and second-opinion renal biopsy work, though its scope is far broader across all pathology subspecialties.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arkana Laboratories

Esoteric Pathology Diagnostic Servicesarkanalabs.com

Arkana Laboratories is a privately held esoteric pathology lab in Little Rock, Arkansas, providing same-day renal biopsy interpretation, neuromuscular diagnostics, APOL1 genotyping, and CRO services to nephrologists, hospitals, and pharma sponsors across 46 U.S. states.

What Arkana Laboratories does

Arkana Laboratories is a center for esoteric pathology headquartered in Little Rock, Arkansas, founded in 2001 by Dr. Patrick Walker as Nephropathology Associates and rebranded under its current name in 2016. The firm operates as the largest renal pathology laboratory in the United States, with 25 board-certified renal pathologists and 3 neuropathologists supported by more than 140 technical and administrative staff, processing more than 90 kidney biopsies per day from referring physicians and hospitals across 46 states. Core diagnostic capabilities span light microscopy, immunofluorescence, electron microscopy, molecular diagnostics (PCR, digital PCR, NanoString), mass spectrometry, and multiplex immunofluorescence imaging; the firm runs a refined 9-hour same-day turnaround workflow for renal biopsies and a 3–5 day turnaround for neuromuscular (muscle and nerve) biopsies.

The business generates revenue through fee-for-service esoteric pathology testing billed to hospitals or third-party payers, supplemented by a PCR-based APOL1 Genotyping Assay (with a No Cost to Patient program sponsored by Vertex Pharmaceuticals), contract research organization (CRO) services for pharmaceutical and biotechnology sponsors via a GCLP-trained, CAP/CLIA/NY-State-certified central lab, a Clinical Biomarker Center offering multiplex imaging in partnership with Quanterix (Akoya) and Vizgen (Ultivue), and a Biorepository supporting kidney disease research. Distribution is direct-to-provider: FedEx-shipped biopsy kits, specimen return logistics, physician phone consultation, faxed reports, and the Arkana Connect mobile app for real-time result access. The firm also operates a one-year renal pathology fellowship, a six-month mid-career transition program, and an extensive educational content program (blog, quizzes, podcast) that functions as a low-cost physician referral channel.

Arkana remains privately held with no disclosed outside investment or parent company. Its research footprint includes 505+ peer-reviewed publications, a 500+-case kidney biopsy biorepository, and access to approximately 50,000 kidney biopsy records spanning 2001–2024, supporting both academic research and pharma-sponsored clinical trial central pathology work. Strategic priorities visible from 2012 onward include sequential vertical expansion (molecular, neuropathology, clinical trials, biomarker center), talent depth as the most concentrated renal pathologist team globally, and partnership-led growth into pharma-sponsored genetic testing channels.

Arkana Laboratories firmographics

Firmographics
Name
Arkana Laboratories
Legal name
Arkana Laboratories
Website
https://arkanalabs.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
101–250 employees
Short description
Arkana Laboratories is a privately held esoteric pathology lab in Little Rock, Arkansas, providing same-day renal biopsy interpretation, neuromuscular diagnostics, APOL1 genotyping, and CRO services to nephrologists, hospitals, and pharma sponsors across 46 U.S. states.
Ownership category
akta.pro rank

Arkana Laboratories industry classification

Industry
Product category
Esoteric Pathology Diagnostic Services
NAICS
Medical Laboratories (621511), Other Scientific and Technical Consulting Services (541690), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories

Keywords

  • Renal pathology services
  • Neuropathology diagnostics
  • Biopsy interpretation
  • APOL1 genotyping
  • Contract research services

Where Arkana Laboratories is headquartered

Location

Headquarters

HQ city
Little Rock
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arkana Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Laboratory Diagnostic Services: Arkana generates revenue by providing fee-for-service esoteric pathology diagnostic testing to hospitals, clinics, nephrologists, and pathologists across 46 states. Services include renal biopsy interpretation (light microscopy, immunofluorescence, electron microscopy), neuropathology (muscle and nerve biopsy analysis), and APOL1 genotyping. Billing can be directed to hospitals or third-party payers.
  2. APOL1 Genotyping Assay: PCR-based genetic testing for APOL1 risk variants (G1, G2, M1) with 24-hour turnaround. Revenue generated from standard laboratory fees for the APOL1 Genotyping Assay. A no-cost testing program is sponsored by Vertex Pharmaceuticals for eligible patients (African ancestry with proteinuria or decreased kidney function, without diabetes).
  3. Contract Research Organization (CRO) Services: Fee-for-service contract research for pharmaceutical and biotechnology companies, academic institutions. Services include board-certified pathologist reads, biomarker identification, stains, transmission electron microscopy, digital PCR, NanoString assays, RNA/DNA extraction, whole slide scanning, AI-based quantitative image analysis, multiplex immunofluorescence, confocal microscopy, laser capture microdissection, and prospective/retrospective referral services. Served as central anatomic pathology lab for clinical trials in glomerulonephritis.
  4. Biorepository Services: De-identified human biologic sample collection and archiving for research purposes, supporting development of diagnostic tests and biomarkers for kidney disease. Samples used to develop serologic and molecular tests.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goNo Cost to Patient APOL1 Testing Program (Vertex Pharmaceuticals sponsored)
OtherPay-as-you-goStandard pathology testing services - billing to hospital or third-party

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Arkana Laboratories product offering

Product offering

Core offering

Arkana Laboratories is a specialized esoteric pathology laboratory that provides kidney and neuromuscular biopsy interpretation, genetic testing (APOL1 genotyping), and contract research services for healthcare providers and pharmaceutical sponsors. It operates the largest team of board-certified renal pathologists in the United States, processing 90+ kidney biopsies per day from 46 states with a 9-hour turnaround, and delivers results via phone consultation, fax, web portal, and a mobile app.

Product overview

Arkana Laboratories is a center for esoteric pathology offering a comprehensive portfolio of diagnostic and research services. The core services include renal pathology with same-day biopsy results (light microscopy, immunofluorescence, and electron microscopy), neuropathology for muscle and nerve biopsies, APOL1 genotyping assay (PCR-based, 24-hour turnaround), and contract research services for clinical trials. Supporting services include a biorepository for kidney disease research and a Clinical Biomarker Center for multiplex imaging. The company also provides educational programs including a one-year renal pathology fellowship and a six-month mid-career transition program. Arkana Connect provides mobile access to patient results. All services are delivered from a single location in Little Rock, Arkansas, with the company processing thousands of kidney biopsies annually from 46 states.

Differentiator

Problem solved

Functional benefit

Products and services

  • Renal Pathology Services Same-day renal biopsy interpretation and diagnosis combining light microscopy, immunofluorescence (IF), and electron microscopy (EM), with clinicopathologic discussion delivered by board-certified nephropathologists. Arkana processes 90+ kidney biopsies per day for adult, pediatric, and transplant cases received from 46 states.
  • Neuropathology Services Expert analysis of muscle and nerve biopsies by three board-certified neuropathologists for inflammatory myopathies, muscular dystrophies, metabolic and congenital myopathies, and neuromuscular disease diagnosis. Includes neurosurgical consultations and autopsy brain analysis, with rapid 3–5 day turnaround and 24-hour preliminary results; accepts fresh or frozen tissue.
  • APOL1 Genotyping Assay PCR-based genetic test detecting APOL1 kidney risk variants (G1, G2, and the M1 protective modifier) in patients of African ancestry, with 24-hour turnaround. A no-cost testing program is available to eligible patients through sponsorship by Vertex Pharmaceuticals and Metis Genetics pre-test counseling.
  • Contract Research Services (CRO) GCLP-trained, CAP/CLIA/NY State-certified contract research organization (CRO) services for pharmaceutical, biotech, and academic sponsors. Includes board-certified pathologist reads, novel biomarker identification, transmission electron microscopy, digital PCR, NanoString assays, RNA/DNA extraction, whole slide scanning, AI-based quantitative image analysis, multiplex immunofluorescence, confocal microscopy, and laser capture microdissection. Arkana has served as a central anatomic pathology laboratory for clinical trials, including in glomerulonephritis.
  • Arkana Biorepository Collection and archiving of de-identified human biologic samples for kidney disease research, supporting development of serologic and molecular diagnostic tests and biomarkers. The biorepository holds hundreds of well-characterized kidney biopsy cases spanning conditions such as membranous glomerulopathy, lupus nephritis, and fibrillary glomerulopathy. Mobile phlebotomy is available via partner ExamOne.
  • Clinical Biomarker Center Certified partner with Quanterix (formerly Akoya Biosciences) and Vizgen (formerly Ultivue) offering multiplex imaging of human tissues for biomarker discovery. Capabilities include Leica BondRx automated staining, Quanterix PhenoImagerHT fluorescence and brightfield whole slide scanning with InForm spectral unmixing, Halo AI image processing, Halo Link remote collaboration, Olympus VS200 high-throughput fluorescence and brightfield scanning, and Leica laser scanning confocal microscopy.
  • Arkana Connect Mobile App Mobile application (iOS and Android) providing physicians secure access to patient biopsy results, including reports and diagnostic images, with two-factor authentication.

Quantifiable outcome

  • Same-day renal biopsy results - from specimen receipt to final results delivered in 9 hours
  • +6 more outcomes

Companies that use Arkana Laboratories

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Arkana Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Arkana Laboratories partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Vertex PharmaceuticalscoreStrategic or Co-development Partner · 1 January 2023Vertex Pharmaceuticals sponsors the No Cost to Patient APOL1 Genotyping Program, enabling healthcare providers to order APOL1-risk variant testing at no cost for qualifying patients (African ancestry with proteinuria or CKD Stages 1-4, without diabetes). Vertex also covers cost of genetic counseling for eligible patients. This partnership advances awareness and diagnosis of APOL1-mediated kidney disease.
  • Metis GeneticscoreStrategic or Co-development Partner · 1 January 2023Metis Genetics provides pre-test genetic counseling to eligible patients in the No Cost to Patient APOL1 Genotyping Program, reviewing benefits and limitations of genetic testing. Genetic counseling available before testing and after results for patients testing positive for APOL1 high-risk variants. Sponsored by Vertex Pharmaceuticals.
  • Quanterix (formerly Akoya Biosciences)coreTechnology or IntegrationArkana Laboratories' Clinical Biomarker Center is a certified partner in Quanterix's CRO Partnership Program, specializing in multiplex imaging of human tissues. Uses Quanterix PhenoImagerHT fluorescence and brightfield whole slide scanning microscope with InForm software for spectral unmixing. Also uses Vizgen (formerly Ultivue) technology.
  • Vizgen (formerly Ultivue)coreTechnology or IntegrationArkana Laboratories' Clinical Biomarker Center specializes in multiplex imaging of human tissues in partnership with Vizgen. Vizgen technology complements Quanterix PhenoImagerHT and Leica BondRx for advanced tissue imaging services.
  • ExamOneminorImplementation/ SI/ Consulting PartnerExamOne provides mobile phlebotomy services for the Arkana Biorepository program. ExamOne sends a mobile phlebotomist to a location of the patient's choosing (home or office) to collect biological samples. Arkana Labs covers cost of mobile phlebotomy and shipping.

Scale indicators8 records

Recent moves11 records

Expansion highlights6 records

Arkana Laboratories competitors and assessment

Company assessment

Broad incumbents

  • ARUP Laboratories: ARUP Laboratories is a nonprofit reference laboratory affiliated with the University of Utah, providing esoteric diagnostic testing including renal pathology, neuropathology, and genetic testing. It competes directly with Arkana for hospital system contracts and offers comparable subspecialty pathologist reads.
  • Quest Diagnostics: Quest Diagnostics is one of the largest U.S. clinical laboratory networks, offering anatomic pathology, esoteric testing, and increasingly subspecialty renal and molecular diagnostics. It competes with Arkana primarily through hospital system contracts and a national logistics network.
  • Laboratory Corporation of America (Labcorp): Labcorp is a major clinical laboratory network with a growing esoteric and specialty pathology portfolio, including the acquired MNG Laboratories for neuromuscular diagnostics. It is a broad competitor to Arkana's diagnostic and CRO services across hospitals and physician offices.
  • Sonic Healthcare USA: Sonic Healthcare USA operates a national network of specialty and reference laboratories including anatomic pathology and esoteric testing services. It competes with Arkana as a broader reference lab alternative for hospital systems seeking subspecialty renal pathology reads.
  • Mayo Clinic Laboratories: Mayo Clinic Laboratories is the reference laboratory arm of Mayo Clinic, offering an extensive esoteric test menu including renal pathology consultations and second-opinion biopsy interpretation. It competes with Arkana for hospital referrals and second-opinion renal biopsy work, though its scope is far broader across all pathology subspecialties.

Direct peers

  • MNG Laboratories (Labcorp): MNG Laboratories is a specialty neuropathology and molecular genetic testing laboratory (now part of Labcorp) focused on neuromuscular disease diagnostics including muscle and nerve biopsy interpretation. It is the most direct head-to-head competitor to Arkana's neuropathology service line.
  • PreventionGenetics (Exact Sciences): PreventionGenetics is a CLIA-certified clinical DNA testing laboratory (now part of Exact Sciences) offering genetic assays including kidney disease risk testing. It is a direct comparable to Arkana's APOL1 genotyping assay and broader molecular diagnostic services.

Emerging players

  • NeoGenomics: NeoGenomics is a specialty oncology-focused clinical laboratory with growing activity in molecular and anatomic pathology CRO services for pharma clinical trials. It overlaps with Arkana's CRO/biopharma service line, particularly for central pathology lab partnerships.
  • PathAI: PathAI is an AI-powered pathology technology company providing machine-learning image analysis tools for diagnostic and CRO applications. It is comparable to Arkana's emerging AI/machine-learning biopsy adequacy work and contract research image analytics capabilities.

Others

  • Eurofins Scientific: Eurofins Scientific is a global laboratory testing group with a substantial clinical diagnostics and pharmaceutical CRO footprint, including specialty biomarker and central lab services. It is comparable as an adjacent CRO/biomarker player serving similar pharmaceutical clients in clinical trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arkana Laboratories social profiles

Digital presence

Arkana Laboratories compliance and trust

Trust signal

Compliance5 records

Arkana Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arkana Laboratories leadership team

Management profile

Number of profiles

Profiles16 records

Arkana Laboratories funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arkana Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arkana Laboratories

What does Arkana Laboratories do?

Arkana Laboratories is a specialized esoteric pathology laboratory that provides kidney and neuromuscular biopsy interpretation, genetic testing (APOL1 genotyping), and contract research services for healthcare providers and pharmaceutical sponsors. It operates the largest team of board-certified renal pathologists in the United States, processing 90+ kidney biopsies per day from 46 states with a 9-hour turnaround, and delivers results via phone consultation, fax, web portal, and a mobile app.

Is Arkana Laboratories a public or private company?

Arkana Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Arkana Laboratories founded?

Arkana Laboratories was founded in 2001. It employs 101 to 250 people.

Where is Arkana Laboratories based?

Arkana Laboratories is headquartered in Little Rock, United States, in the North America region.

How does Arkana Laboratories make money?

Four revenue lines are on record. Clinical Laboratory Diagnostic Services are the primary driver. The others are APOL1 Genotyping Assay, contract Research Organization (CRO) Services and biorepository Services.

Who are Arkana Laboratories's main competitors?

Broad incumbents on record are ARUP Laboratories, Quest Diagnostics, Laboratory Corporation of America (Labcorp), Sonic Healthcare USA and Mayo Clinic Laboratories. Direct peers are MNG Laboratories (Labcorp) and PreventionGenetics (Exact Sciences). Emerging players are NeoGenomics and PathAI. Eurofins Scientific is listed as an others.

Does Arkana Laboratories have an API?

No public API is recorded for Arkana Laboratories.

What industry is Arkana Laboratories in?

Arkana Laboratories's product category is Esoteric Pathology Diagnostic Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTriCore Go-Live with the World's First Systems-Agnostic Laboratory Exchange Network; X-Lab's LabgnosticTriCore, an independent clinical laboratory in Albuquerque, New Mexico, has gone live with Labgnostic, becoming one of the first two labs in the US to use this systems-agnostic laboratory exchange network, alongside Arkana Labs in Little Rock, Arkansas. The network enables electronic orders and results workflows between labs without manual entry, at a fraction of the typical cost of point-to-point interfaces which average $25,000 per deployment plus $3,000-$5,000 in yearly service fees. X-Lab's CEO indicated this represents the first step toward building a national laboratory exchange in the US, leveraging technology that has already achieved 100% coverage across the UK National Health Service.PR NewswireArkana Labs Go-Live on the World's First Systems-Agnostic Laboratory Exchange Network; X-Lab's LabgnosticArkana Labs, a renal pathology specialty lab in Little Rock, Arkansas, became one of the first two laboratories to go live on X-Lab's Labgnostic network in a pilot with TriCore Reference Laboratories, enabling electronic order and result workflows to replace paper-based processes. The systems-agnostic platform allows labs to connect through a single interface to exchange samples and data at a fraction of the cost of traditional point-to-point interfaces. X-Lab's CEO described the launch as a first step toward building a national laboratory exchange network in the US, with the platform already serving nearly 200 diagnostic organizations across Europe and the UK.ArkansasedcArkana Laboratories to Expand Little Rock Operations, Create 74 New JobsArkana Laboratories announced on September 7, 2022 that it will expand its Little Rock, Arkansas operations, creating 74 new jobs over five years. The company will invest more than $30 million and add 10,000 square feet to its 90,000-square-foot building, bringing total employment to about 220. Expansion is expected to be completed by 2024.